Two cases of immune thrombocytopenia associated with pembrolizumab-Reference-Cited by-同舟云学术

Two cases of immune thrombocytopenia associated with pembrolizumab

Published:2016-02 Issue: Volume:54 Page:172-174
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Le Roy Audrey,Kempf Emmanuelle,Ackermann Felix,Routier Emilie,Robert Caroline,Turpin Anthony,Marabelle Aurélien,Mateus Christine,Michot Jean-Marie,Lambotte Olivier

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference5 articles.

1. The PD-1 pathway in tolerance and autoimmunity;Francisco;Immunol Rev,2010

2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

3. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015

4. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma;Ansell;N Engl J Med,2014

5. Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection;Bata;Korean J Radiol,2012

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review;International Immunopharmacology;2024-03

2. Case report: combination of immune-related thrombocytopenia and myocarditis in а patient treated with immune checkpoint inhibitors for non‑small cell lung cancer;Malignant tumours;2023-03-07

3. Multiple Autoimmune Complications After a Single Dose of Pembrolizumab;Cureus;2023-03-07

4. Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review;Annals of Hematology;2021-12-28

5. Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis;Journal of Immunotherapy;2021-09-01